258 related articles for article (PubMed ID: 17445951)
1. Synthesis and evaluation of new difluoromethyl azoles as antileishmanial agents.
Ferreira SB; Costa MS; Boechat N; Bezerra RJ; Genestra MS; Canto-Cavalheiro MM; Kover WB; Ferreira VF
Eur J Med Chem; 2007; 42(11-12):1388-95. PubMed ID: 17445951
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel tetrahydronaphthyl azoles and related cyclohexyl azoles as antileishmanial agents.
Marrapu VK; Srinivas N; Mittal M; Shakya N; Gupta S; Bhandari K
Bioorg Med Chem Lett; 2011 Mar; 21(5):1407-10. PubMed ID: 21295472
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of 3-(imidazol- 1-ylmethyl)indoles as antileishmanial agents. Part II.
Giraud F; Loge C; Pagniez F; Crepin D; Barres S; Picot C; Le Pape P; Le Borgne M
J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1067-75. PubMed ID: 19555181
[TBL] [Abstract][Full Text] [Related]
5. Thiopurine derivatives containing triazole and steroid: synthesis, antimalarial and antileishmanial activities.
Corrales RC; de Souza NB; Pinheiro LS; Abramo C; Coimbra ES; Da Silva AD
Biomed Pharmacother; 2011 Jun; 65(3):198-203. PubMed ID: 21111565
[TBL] [Abstract][Full Text] [Related]
6. Antileishmanial activities and mechanisms of action of indole-based azoles.
Pagniez F; Abdala-Valencia H; Marchand P; Le Borgne M; Le Baut G; Robert-Piessard S; Le Pape P
J Enzyme Inhib Med Chem; 2006 Jun; 21(3):277-83. PubMed ID: 16918075
[TBL] [Abstract][Full Text] [Related]
7. Aryloxy cyclohexyl imidazoles: a novel class of antileishmanial agents.
Srinivas N; Palne S; Nishi ; Gupta S; Bhandari K
Bioorg Med Chem Lett; 2009 Jan; 19(2):324-7. PubMed ID: 19091566
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of substituted aryloxy alkyl and aryloxy aryl alkyl imidazoles as antileishmanial agents.
Bhandari K; Srinivas N; Marrapu VK; Verma A; Srivastava S; Gupta S
Bioorg Med Chem Lett; 2010 Jan; 20(1):291-3. PubMed ID: 19913413
[TBL] [Abstract][Full Text] [Related]
9. An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy.
Emami S; Tavangar P; Keighobadi M
Eur J Med Chem; 2017 Jul; 135():241-259. PubMed ID: 28456033
[TBL] [Abstract][Full Text] [Related]
10. The potential effects of new synthetic drugs against Leishmania amazonensis and Trypanosoma cruzi.
Canto-Cavalheiro MM; Echevarria A; Araujo CA; Bravo MF; Santos LH; Jansen AM; Leon LL
Microbios; 1997; 90(362):51-60. PubMed ID: 9301071
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antileishmanial evaluation of 1-aryl-4-(4,5-dihydro-1H-imidazol-2-yl)-1H-pyrazole derivatives.
dos Santos MS; Oliveira ML; Bernardino AM; de Léo RM; Amaral VF; de Carvalho FT; Leon LL; Canto-Cavalheiro MM
Bioorg Med Chem Lett; 2011 Dec; 21(24):7451-4. PubMed ID: 22055204
[TBL] [Abstract][Full Text] [Related]
12. Preparation and antileishmanial activity of lipophilic N-alkyl diamines.
da Costa CF; Coimbra ES; Braga FG; dos Reis RC; da Silva AD; de Almeida MV
Biomed Pharmacother; 2009 Jan; 63(1):40-2. PubMed ID: 18262385
[TBL] [Abstract][Full Text] [Related]
13. Potent naphthoquinones against antimony-sensitive and -resistant Leishmania parasites: synthesis of novel α- and nor-α-lapachone-based 1,2,3-triazoles by copper-catalyzed azide-alkyne cycloaddition.
Guimarães TT; Pinto Mdo C; Lanza JS; Melo MN; do Monte-Neto RL; de Melo IM; Diogo EB; Ferreira VF; Camara CA; Valença WO; de Oliveira RN; Frézard F; da Silva EN
Eur J Med Chem; 2013 May; 63():523-30. PubMed ID: 23535320
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of novel 4-aminoquinoline/1,2,3-triazole hybrids against Leishmania amazonensis.
Glanzmann N; Antinarelli LMR; da Costa Nunes IK; Pereira HMG; Coelho EAF; Coimbra ES; da Silva AD
Biomed Pharmacother; 2021 Sep; 141():111857. PubMed ID: 34323702
[TBL] [Abstract][Full Text] [Related]
15. Effect of 1,2,3-triazole salts, non-classical bioisosteres of miltefosine, on Leishmania amazonensis.
Stroppa PHF; Antinarelli LMR; Carmo AML; Gameiro J; Coimbra ES; da Silva AD
Bioorg Med Chem; 2017 Jun; 25(12):3034-3045. PubMed ID: 28433512
[TBL] [Abstract][Full Text] [Related]
16. Dihydropyrido[2,3-d]pyrimidines as a new class of antileishmanial agents.
Agarwal A; Ramesh ; Ashutosh ; Goyal N; Chauhan PM; Gupta S
Bioorg Med Chem; 2005 Dec; 13(24):6678-84. PubMed ID: 16126395
[TBL] [Abstract][Full Text] [Related]
17. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and preliminary evaluation of new ursolic and oleanolic acids derivatives as antileishmanial agents.
Gnoatto SC; Dalla Vechia L; Lencina CL; Dassonville-Klimpt A; Da Nascimento S; Mossalayi D; Guillon J; Gosmann G; Sonnet P
J Enzyme Inhib Med Chem; 2008 Oct; 23(5):604-10. PubMed ID: 18608757
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of thiadiazine derivatives against Leishmania amazonensis.
Monzote L; Montalvo AM; Fonseca L; Pérez R; Suárez M; Rodríguez H
Arzneimittelforschung; 2005; 55(4):232-8. PubMed ID: 15901047
[TBL] [Abstract][Full Text] [Related]
20. Antileishmanial properties of tropical marine algae extracts.
Freile-Pelegrin Y; Robledo D; Chan-Bacab MJ; Ortega-Morales BO
Fitoterapia; 2008 Jul; 79(5):374-7. PubMed ID: 18504078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
